1
/
of
0
FDA Summary Basis of Approval – Naltrexone Hydrochloride (Revia) Tablet 50 mg for TEVA WOMENS HEALTH INC, NDA N018932
FDA Summary Basis of Approval – Naltrexone Hydrochloride (Revia) Tablet 50 mg for TEVA WOMENS HEALTH INC, NDA N018932
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request Contents: Summary Basis of Approval for Naltrexone Hydrochloride (Revia) Tablet Oral 50 mg for TEVA WOMENS HEALTH INC, NDA N018932
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details